Visit this page often for weekly blog posts that we think you’ll find interesting and helpful.

Topics may range from “Connecting a care team to effectively implement an individualized education plan” to “Elder-specific issues in care coordination.” We think unlocking potential and enhancing care outcomes includes keeping everyone informed of new and better ways to organize and coordinate care in patient-centric ways…

Clinical Trial Collaborations Create New Hope And Challenges

If you read news articles on the pharmaceutical industry, you will readily notice that clinical trial collaborations are the new normal. The feeds are littered with who’s who and who is collaborating with whom. It’s an exciting time for those who are working hard to advance medicine for all mankind. 


What pharmaceutical entities have to offer each other in terms of advancing research cannot be ignored. Collaborating around a common issue would never happen in most industries. Companies are usually keen to crush their competition and researchers are leery of having their theories leaked before their time. Not so with the pharmaceutical industry, it seems. We are likely all better for it. 


What the next wave of clinical trial collaborations looks like could be a whole lot more than we ever realized. Harnessing the power of information sharing is the key to what makes clinical trial collaborations work. Everyone involved wants a piece of the winner’s prize. How can the pharmaceutical industry do more to enable clinical trial collaborations to be more successful?


Clinical Trial Collaborations Involve Lots Of Transparency


These kinds of mutual endeavors have to come with lots of trust and tons of transparency. There is a lot at stake in general when it comes to a clinical trial. Data matters for everyone. Sharing what everyone has so far on the project is only a fraction of the battle. Real transparency comes in sharing what comes out of the collaboration and helping each other out so it works out for both parties. Failing to share and provide all of the information in a timely fashion can completely derail clinical trial collaborations. A lot needs to happen and too often clinical trials are overworked and understaffed which put data sharing at risk. 


Then there is the trial participant. You have to be careful who has what information and where it goes when it comes to HIPAA. Getting trial participants properly recruited is only the beginning. Keeping their information safe in clinical trial collaborations is another. The collaboration has to include equal access to data. All parties also need total transparency to the trial participant as to who is seeing the data and where it is stored.


Could trial participants be able to see the same data in clinical trial collaborations as the entities who are collaborating? There is already a study on patient access to their own medical records and how that transparency is yielding very positive results. The study highlighted its benefits to patient satisfaction and follow-through on treatment plans. Clinical trial collaborations would do well to look into how that might work in a clinical trial setting for better participant completion. CRAACO is also another great reason to include the trial participant in the collaboration and sharing of information. If we want trial participants to think of a clinical trial as another medical treatment, the pharmaceutical industry will need to get their minds around mirroring the information-sharing practices you can find in most healthcare systems today. 


Finding The Right Tools To Make Clinical Trial Collaborations More Cohesive


Deciding to improve transparency and information sharing across the entire spectrum of participants in clinical trial collaborations means the pharmaceutical industry needs to rethink how it is collecting and disseminating data now. If everyone is using their own systems and dumping out reports for others to put into their own, it’s hardly sharing and collaborating on information, isn’t it? There needs to be a tool that allows everyone to come around one set of data in one system to view, comment on, and monitor. 


Imagine a trial participant being able to share in realtime and get answers from either part of the clinical trial collaboration. What would that be like for the trial participant? What would that mean for clinical trial collaborations as a whole?


Such a system of data collection, information sharing, and collaboration already exists. eCare Vault is the first solution of it’s kind to make this kind of collaboration a reality in the pharmaceutical industry in ways that never existed before. There are information sharing tools in the industry now, but none have the all-encompassing collaboration that eCare Vault has, especially with trial participant access and input.  


The kind of clinical trial collaborations that really matter are ready and waiting with eCare Vault. If you are interested in seeing what eCare Vault can do for your next clinical trial, contact us today for a free consultation. 

Thank you for sharing!